JP2012214469A - Emulsion composition - Google Patents
Emulsion composition Download PDFInfo
- Publication number
- JP2012214469A JP2012214469A JP2012082773A JP2012082773A JP2012214469A JP 2012214469 A JP2012214469 A JP 2012214469A JP 2012082773 A JP2012082773 A JP 2012082773A JP 2012082773 A JP2012082773 A JP 2012082773A JP 2012214469 A JP2012214469 A JP 2012214469A
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- component
- hydrogen atom
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 239000000839 emulsion Substances 0.000 title claims abstract description 23
- -1 stearoyl methyl Chemical group 0.000 claims abstract description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229940106189 ceramide Drugs 0.000 claims abstract description 24
- 125000005250 alkyl acrylate group Chemical group 0.000 claims abstract description 17
- 229920001577 copolymer Polymers 0.000 claims abstract description 16
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims abstract description 15
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims abstract description 15
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims abstract description 14
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001783 ceramides Chemical class 0.000 claims abstract description 11
- 229960000541 cetyl alcohol Drugs 0.000 claims abstract description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 10
- SKQOTPRMPUYWSH-FQEVSTJZSA-N CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O Chemical class CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O SKQOTPRMPUYWSH-FQEVSTJZSA-N 0.000 claims abstract description 9
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims abstract description 9
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940081618 glyceryl monobehenate Drugs 0.000 claims abstract description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- OOWQBDFWEXAXPB-UHFFFAOYSA-N 1-O-palmitylglycerol Chemical compound CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 claims abstract description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 56
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 55
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 52
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 35
- 229920006395 saturated elastomer Polymers 0.000 claims description 32
- 239000012071 phase Substances 0.000 claims description 24
- 125000004122 cyclic group Chemical group 0.000 claims description 23
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 23
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 18
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 15
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 14
- 125000004043 oxo group Chemical group O=* 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 12
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 12
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 8
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 8
- 229940071136 stearoyl glutamate Drugs 0.000 claims description 8
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 7
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 7
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 229940104261 taurate Drugs 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 229920003169 water-soluble polymer Polymers 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 229930182558 Sterol Natural products 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 150000003432 sterols Chemical class 0.000 claims description 3
- 235000003702 sterols Nutrition 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 229930195712 glutamate Natural products 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 abstract description 8
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 abstract 1
- 229940073743 steareth-20 methacrylate Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 47
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 150000002632 lipids Chemical class 0.000 description 12
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 11
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 11
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007764 o/w emulsion Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 5
- 235000020778 linoleic acid Nutrition 0.000 description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 5
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000002688 persistence Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000235 small-angle X-ray scattering Methods 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229940099417 ceramide 2 Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- ALYQTSXGWBNEQC-VWMHFEHESA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;octadecanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.CCCCCCCCCCCCCCCCCC(O)=O ALYQTSXGWBNEQC-VWMHFEHESA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- SJMBETQHZHCXGR-UHFFFAOYSA-N 1-(2-octoxyethoxy)octane Chemical compound CCCCCCCCOCCOCCCCCCCC SJMBETQHZHCXGR-UHFFFAOYSA-N 0.000 description 1
- XMFUMMRWIFOQDQ-UHFFFAOYSA-N 1-(4-methylpentan-2-yloxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOC(C)CC(C)C XMFUMMRWIFOQDQ-UHFFFAOYSA-N 0.000 description 1
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- MACVUTCNLULHLQ-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O MACVUTCNLULHLQ-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WAYLDHLWVYQNSQ-KEFDUYNTSA-N N-2-hydroxylignoceroylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC WAYLDHLWVYQNSQ-KEFDUYNTSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229940095137 ceramide 6 ii Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- OTKJDMGTUTTYMP-UHFFFAOYSA-N dihydrosphingosine Natural products CCCCCCCCCCCCCCCC(O)C(N)CO OTKJDMGTUTTYMP-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- SXBBFOVRSQCYFE-SQKCAUCHSA-L disodium;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O SXBBFOVRSQCYFE-SQKCAUCHSA-L 0.000 description 1
- MVFPQYVAVMINHP-UHFFFAOYSA-L disodium;octadecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCCOP([O-])([O-])=O MVFPQYVAVMINHP-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULMXYNZCSJBKOQ-UHFFFAOYSA-N n-(3-hexadecoxy-3-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOC(O)CCN(CCO)C(=O)CCCCCCCCCCCCCCC ULMXYNZCSJBKOQ-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000002465 nonacosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000002469 tricosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、乳化組成物に関する。 The present invention relates to an emulsified composition.
皮膚の最外層の角層には、角層細胞とその間隙を埋める細胞間脂質が存在する。その大半は、α−ゲル構造をとっており、皮膚に対して、外部からの物質の侵入、内部からの水分蒸散を抑制すると同時に、そのもの自身が水分を保持することで、皮膚の柔軟性やなめらかな外観を保つ機能を有している。
一般に、細胞間脂質、特にセラミドの減少により、好ましくない肌状態が引き起こされることが知られており、セラミドを外用で補うことは、肌の機能低下の改善につながると考えられている。
In the outermost stratum corneum of the skin, there are stratum corneum cells and intercellular lipids that fill the gaps. Most of them have an α-gel structure, which suppresses the invasion of substances from the outside and moisture evaporation from the inside, while at the same time holding the moisture itself, Has the function of maintaining a smooth appearance.
In general, it is known that an unfavorable skin condition is caused by a decrease in intercellular lipids, particularly ceramide, and supplementing ceramide with an external application is considered to lead to improvement in skin functional deterioration.
しかしながら、セラミドは、高融点で結晶性が高く、外用剤等に配合することが困難であるため、安定に配合することが種々検討されている。
例えば、特許文献1には、セラミド類と、グリセリンモノ脂肪酸エステル、高級アルコールを特定の割合で組み合わせた乳化組成物が、セラミドの結晶析出が抑えられ、水分を保持しやすいα−ゲル構造を形成し、保湿効果が高いことが記載されている。
また、特定の糖アルコール又は2単糖若しくは3単糖を更に組み合わせることにより、α−ゲルの水分保持能をより高めることができ、水分を長時間皮膚に残留させ、皮膚の状態を改善することも検討されている(特許文献2、特許文献3)。
However, since ceramide has a high melting point and high crystallinity and is difficult to be blended into an external preparation or the like, various studies have been made on blending it stably.
For example, Patent Document 1 discloses that an emulsified composition in which ceramides, glycerin monofatty acid esters and higher alcohols are combined at a specific ratio forms an α-gel structure in which ceramide crystal precipitation is suppressed and moisture is easily retained. In addition, it is described that the moisturizing effect is high.
Further, by further combining a specific sugar alcohol or a disaccharide or a trisaccharide, the water retention ability of the α-gel can be further increased, and moisture can remain on the skin for a long time, thereby improving the skin condition. Are also being studied (Patent Documents 2 and 3).
しかしながら、これらの組成物はα−ゲル構造を形成するものの、低粘度で皮膚に塗布しづらいため、保湿効果を有する皮膜が形成しても、その皮膜は脆く、均一に肌を覆うことができず、十分な水分保持能を発揮しにくいものであった。
また、皮膜が柔軟性及び弾性に欠けるため、塗布後の肌には特有のきしみ感・ざらつき感があり、良好な使用感触が得られない。更に、塗布後の見た目の滑らかさに欠け、肌の外観向上効果が得られないという問題もあった。
However, although these compositions form an α-gel structure, they are low in viscosity and difficult to apply to the skin, so even if a film having a moisturizing effect is formed, the film is brittle and can uniformly cover the skin. Therefore, it was difficult to exhibit sufficient water retention ability.
Further, since the film lacks flexibility and elasticity, the skin after application has a unique squeaky feeling and rough feeling, and a good feeling of use cannot be obtained. Furthermore, there is a problem that the appearance is not smooth after application and the effect of improving the appearance of the skin cannot be obtained.
本発明は、塗布膜が柔軟性及び弾性を有し、肌を均一に覆うことができ、水分保持能が高く、肌感触が滑らかで、見た目も滑らかにすることができる乳化組成物を提供するものである。 The present invention provides an emulsified composition in which the coating film has flexibility and elasticity, can uniformly cover the skin, has a high moisture retention ability, has a smooth skin feel, and can also have a smooth appearance. Is.
本発明者らは、水分保持能が高まる設計のα−ゲルに対し、特定の水溶性高分子を組み合わせることにより、高粘度で弾性的な液性が得られ、塗布膜が柔軟性及び弾性を有するため、肌を均一に覆うことができ、水分保持能を高め、肌感触が滑らかで、見た目も滑らかにすることができる乳化組成物が得られることを見出した。 The inventors of the present invention can obtain an elastic liquid property with high viscosity by combining a specific water-soluble polymer with an α-gel designed to increase moisture retention, and the coating film has flexibility and elasticity. Therefore, it has been found that an emulsified composition can be obtained that can uniformly cover the skin, enhances moisture retention, has a smooth skin feel, and can have a smooth appearance.
本発明は、次の成分(A)、(B)、(C)、(D)及び(F1):
(A)次の一般式(1)
The present invention includes the following components (A), (B), (C), (D) and (F1):
(A) The following general formula (1)
(式中、Z1は、グリセリン、ソルビタン、ソルビトール又はショ糖残基で2個以上のヒドロキシル基を有する構造を示し、Y1は、エステル結合基又はエーテル結合基を示し、Rは、炭素数14〜22の炭化水素基を示し、nは1〜4の数を示す)
で表される化合物 0.001〜10質量%、
(B)炭素数14〜22の高級アルコール及びステロール類から選ばれる1種以上の化合物 0.001〜10質量%、
(C)一般式(2):
(In the formula, Z 1 represents a structure having two or more hydroxyl groups in a glycerin, sorbitan, sorbitol or sucrose residue, Y 1 represents an ester bond group or an ether bond group, and R represents the number of carbon atoms. 14 represents a hydrocarbon group of 22 to 22 and n represents a number of 1 to 4)
0.001 to 10% by mass of a compound represented by
(B) one or more compounds selected from higher alcohols having 14 to 22 carbon atoms and sterols 0.001 to 10% by mass,
(C) General formula (2):
(式中、R1はヒドロキシル基、カルボニル基若しくはアミノ基が置換していてもよい、炭素数4〜30の直鎖、分岐鎖若しくは環状の飽和若しくは不飽和の炭化水素基を示し;Zはメチレン基、メチン基又は酸素原子を示し;X1、X2及びX3は各々独立して水素原子、ヒドロキシル基又はアセトキシ基を示し、X4は水素原子、アセチル基又はグリセリル基を示すか、隣接する酸素原子と一緒になってオキソ基を形成し(但し、Zがメチン基のとき、X1とX2のいずれか一方が水素原子であり、他方は存在しない。X4がオキソ基を形成するとき、X3は存在しない。);R2及びR3は各々独立して水素原子、ヒドロキシル基、ヒドロキシメチル基又はアセトキシメチル基を示し;R4はヒドロキシル基、カルボニル基又はアミノ基が置換していてもよい、主鎖にエーテル結合、エステル結合又はアミド結合を有していてもよい炭素数5〜60の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基を示し;R5は水素原子を示すか、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基及びアセトキシ基から選ばれる置換基を有していてもよい、総炭素数1〜30の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基を示し;破線部は不飽和結合であってもよいことを示す)で表される化合物 0.001〜15質量%、
(D)アニオン界面活性剤 0.00025〜10質量%、
(F1)水を含む水相I
を混合して乳化し、冷却する工程1の後に、
(E)アルキル変性ポリアクリル酸系ビニルポリマー及びアルキル変性多糖類系ポリマー
から選ばれる水溶性高分子 0.001〜6質量%、及び
(F2)水を含む水相IIをさらに混合する工程2
を備える乳化組成物の製造方法を提供するものである。
(Wherein R 1 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 4 to 30 carbon atoms which may be substituted by a hydroxyl group, a carbonyl group or an amino group; A methylene group, a methine group or an oxygen atom; X 1 , X 2 and X 3 each independently represents a hydrogen atom, a hydroxyl group or an acetoxy group, and X 4 represents a hydrogen atom, an acetyl group or a glyceryl group, Combined with the adjacent oxygen atom to form an oxo group (provided that when Z is a methine group, one of X 1 and X 2 is a hydrogen atom and the other does not exist. X 4 represents an oxo group. When formed, X 3 is not present.); R 2 and R 3 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an acetoxymethyl group; R 4 represents a hydroxyl group, a carbonyl group or an amino group. Replace A linear, branched or cyclic saturated or unsaturated hydrocarbon group having 5 to 60 carbon atoms which may have an ether bond, an ester bond or an amide bond in the main chain; 5 represents a hydrogen atom, or may have a substituent selected from a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an acetoxy group, and is a linear or branched saturated or unsaturated group having 1 to 30 carbon atoms in total A compound represented by the following formula: 0.001 to 15% by mass;
(D) Anionic surfactant 0.00025-10 mass%,
(F1) Water phase I containing water
Are mixed, emulsified, and cooled, after step 1,
(E) Step 2 of further mixing water-soluble polymer 0.001 to 6% by mass selected from alkyl-modified polyacrylic acid vinyl polymer and alkyl-modified polysaccharide polymer, and (F2) water phase II containing water
The manufacturing method of an emulsion composition provided with this is provided.
また、本発明は、次の成分(A)、(B)、(C)、(D)、(E)及び(F):
(A)モノベヘン酸グリセリル又はモノセチルグリセリルエーテル 0.001〜10質量%、
(B)セタノール又はステアリルアルコール 0.001〜10質量%、
(C)一般式(3)又は一般式(4)で表されるセラミド類 0.001〜15質量%、
The present invention also includes the following components (A), (B), (C), (D), (E) and (F):
(A) glyceryl monobehenate or monocetyl glyceryl ether 0.001 to 10% by mass,
(B) cetanol or stearyl alcohol 0.001 to 10% by mass,
(C) Ceramides represented by general formula (3) or general formula (4) 0.001 to 15% by mass,
(式中、R11はヒドロキシル基が置換していてもよい炭素数7〜19の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基を示し;Z1はメチレン基又はメチン基を示し;X5、X6、及びX7は各々独立して水素原子、ヒドロキシル基又はアセトキシ基を示し;X8は水素原子を示すか、隣接する酸素原子と一緒になってオキソ基を形成し(但し、Z1がメチン基のとき、X5とX6のいずれか一方が水素原子であり、他方は存在しない。X8がオキソ基を形成するとき、X7は存在しない。);R12はヒドロキシメチル基又はアセトキシメチル基を示し;R13は水素原子を示すか、炭素数1〜4のアルキル基を示し;R14はヒドロキシル基が置換していてもよい炭素数5〜30の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基であるか、又は該アルキル基のω末端に、ヒドロキシル基が置換していてもよい炭素数8〜22の直鎖又は分岐鎖の飽和又は不飽和の脂肪酸がエステル結合したものを示し;破線部は不飽和結合であってもよいことを示す。) (Wherein R 11 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 7 to 19 carbon atoms which may be substituted by a hydroxyl group; Z 1 represents a methylene group or a methine group; X 5 , X 6 and X 7 each independently represents a hydrogen atom, a hydroxyl group or an acetoxy group; X 8 represents a hydrogen atom or together with an adjacent oxygen atom, forms an oxo group. (However, when Z 1 is a methine group, one of X 5 and X 6 is a hydrogen atom and the other does not exist. When X 8 forms an oxo group, X 7 does not exist.); R 12 represents a hydroxymethyl group or an acetoxymethyl group; R 13 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R 14 has 5 to 30 carbon atoms which may be substituted by a hydroxyl group Whether it is a linear, branched or cyclic saturated or unsaturated hydrocarbon group Or a linear or branched saturated or unsaturated fatty acid having 8 to 22 carbon atoms which may be substituted with a hydroxyl group at the ω-terminal of the alkyl group; Indicates that it may be a bond.)
(式中、R15は、ヒドロキシル基が置換していてもよい炭素数10〜22の直鎖、分岐鎖若しくは環状の飽和若しくは不飽和の炭化水素基又は水素原子を示し;X9は水素原子、アセチル基又はグリセリル基を示し;R16はヒドロキシル基又はアミノ基が置換していてもよい炭素数5〜22の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基であるか、又は該炭化水素基のω末端に、ヒドロキシル基が置換していてもよい炭素数8〜22の直鎖又は分岐鎖の飽和又は不飽和の脂肪酸がエステル結合したものを示し;R17は水素原子を示すか、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基又はアセトキシ基が置換していてもよい総炭素数1〜30のアルキル基を示す。)
(D)ステアロイルグルタミン酸塩、ステアロイルメチルタウリン塩又はポリオキシエチレンステアリルエーテルリン酸塩 0.00025〜10質量%、
(E)(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース又はステアロキシPGヒドロキシエチルセルローススルホン酸Na 0.001〜6質量%、
(F)水
を含有する乳化組成物を提供するものである。
(In the formula, R 15 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group or a hydrogen atom having 10 to 22 carbon atoms which may be substituted with a hydroxyl group; X 9 represents a hydrogen atom; , An acetyl group or a glyceryl group; R 16 is a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 5 to 22 carbon atoms which may be substituted with a hydroxyl group or an amino group; Or a hydrocarbon group having an ester bond with a linear or branched saturated or unsaturated fatty acid having 8 to 22 carbon atoms which may be substituted with a hydroxyl group at the ω-terminal; R 17 represents a hydrogen atom; Or a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an acetoxy group which may be substituted is an alkyl group having 1 to 30 carbon atoms in total.
(D) stearoyl glutamate, stearoyl methyl taurate or polyoxyethylene stearyl ether phosphate 0.00025-10 mass%,
(E) (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / steareth methacrylate-20) copolymer, laureth-13PG hydroxyethyl cellulose or stearoxy PG hydroxyethyl cellulose sulfonate 0.001-6 mass %,
(F) An emulsified composition containing water is provided.
本発明の乳化組成物は、高粘度で弾性的な液性が得られ、塗布膜が柔軟性及び弾性を有するため、肌を均一に覆うことができ、水分保持能が高く、肌感触が滑らかで、見た目も滑らかにすることができる。 The emulsified composition of the present invention has a high viscosity and an elastic liquid property, and since the coating film has flexibility and elasticity, it can uniformly cover the skin, has a high moisture retention ability, and has a smooth skin feel. And you can make it look smooth.
本発明で用いる成分(A)は、前記一般式(1)で表されるものである。
式中、Rで示される炭素数14〜22の炭化水素基としては、直鎖炭化水素基が好ましく、例えば、ミリスチル基、パルミチル基、ステアリル基、ベヘニル基等の直鎖アルキル基;パルミトイル基、オレイル基等が挙げられる。
一般式(1)で表される化合物としては、グリセリンモノ脂肪酸エステル、ソルビタンモノ脂肪酸エステル、ソルビタンジ脂肪酸エステル、ソルビトールモノ脂肪酸エステル、ソルビトールジ脂肪酸エステル、ショ糖モノ脂肪酸エステル、グリセリンモノアルキルエーテル等が挙げられる。
The component (A) used in the present invention is represented by the general formula (1).
In the formula, the hydrocarbon group having 14 to 22 carbon atoms represented by R is preferably a linear hydrocarbon group, for example, a linear alkyl group such as a myristyl group, a palmityl group, a stearyl group, a behenyl group; a palmitoyl group; An oleyl group etc. are mentioned.
Examples of the compound represented by the general formula (1) include glycerin monofatty acid ester, sorbitan monofatty acid ester, sorbitan difatty acid ester, sorbitol monofatty acid ester, sorbitol difatty acid ester, sucrose monofatty acid ester, glycerin monoalkyl ether, and the like. Can be mentioned.
成分(A)としては、グリセリンモノ脂肪酸エステル、ソルビタンモノ脂肪酸エステル、グリセリンモノアルキルエーテルが好ましい。中でも、モノパルミチン酸グリセリル、モノステアリン酸グリセリル、モノベヘン酸グリセリル、モノステアリン酸ソルビタン、モノセチルグリセリルエーテル、モノステアリルグリセリルエーテルが好ましく、更に、後述するラメラ状の皮膜の形成性、保水性が向上する観点から、モノベヘン酸グリセリル又はモノセチルグリセリルエーテルがより好ましい。 As the component (A), glycerin monofatty acid ester, sorbitan monofatty acid ester, and glycerin monoalkyl ether are preferable. Among them, glyceryl monopalmitate, glyceryl monostearate, glyceryl monobehenate, sorbitan monostearate, monocetyl glyceryl ether, and monostearyl glyceryl ether are preferable, and further, a lamellar film-forming property and water retention described later are improved. From the viewpoint, glyceryl monobehenate or monocetyl glyceryl ether is more preferable.
成分(A)は、1種以上を用いることができ、全組成中に0.001〜10質量%含有され、好ましくは0.05〜7質量%、更に好ましくは、0.25〜3質量%含有される。この範囲内であれば、本発明の乳化組成物を皮膚に塗布後、乾燥過程で皮膚表面に後述する成分(B)〜(E)が構成する脂質層と水分層が交互に並ぶラメラ状皮膜を形成することができる。この結果、層間に水分を保持できるため水分保持能が高まるので好ましい。更に塗布膜の使用感触も良くなるので好ましい。 One or more types of component (A) can be used, and 0.001-10 mass% is contained in the whole composition, Preferably it is 0.05-7 mass%, More preferably, it is 0.25-3 mass%. Contained. Within this range, after applying the emulsion composition of the present invention to the skin, a lamellar film in which lipid layers and water layers composed of components (B) to (E) described later are alternately arranged on the skin surface during the drying process Can be formed. As a result, moisture can be retained between the layers, so that the moisture retention ability is increased, which is preferable. Furthermore, the feeling of use of the coating film is improved, which is preferable.
本発明で用いる成分(B)のうち、高級アルコールは、炭素数14〜22、好ましくは炭素数16〜18のものである。例えば、ミリスチルアルコール、セタノール、ステアリルアルコール、ベヘニルアルコール等が挙げられる。
これらのうち、セタノール、ステアリルアルコールが好ましく、更にセタノールが好ましい。
Among the components (B) used in the present invention, the higher alcohol has 14 to 22 carbon atoms, preferably 16 to 18 carbon atoms. For example, myristyl alcohol, cetanol, stearyl alcohol, behenyl alcohol and the like can be mentioned.
Of these, cetanol and stearyl alcohol are preferable, and cetanol is more preferable.
また、成分(B)のうち、ステロール類としては、コレステロール、フィトステロールが挙げられる。フィトステロールは、β−シトステロール、カンペステロール、スティグマステロール、ブラシカステロール等の植物ステロールの総称であり、その組成は限定されるものではない。 Moreover, cholesterol and phytosterol are mentioned as a sterol among components (B). Phytosterol is a general term for plant sterols such as β-sitosterol, campesterol, stigmasterol, and brassicasterol, and the composition thereof is not limited.
成分(B)は、1種以上を用いることができ、全組成中に0.001〜10質量%含有され、好ましくは0.05〜7質量%、更に好ましくは0.1〜3質量%含有される。この範囲内であれば、本発明の乳化組成物を皮膚に塗布後、乾燥過程で皮膚表面に前述の成分(A)及び、後述する成分(C)〜(E)が構成する脂質層と水分層が交互に並ぶラメラ状皮膜を形成することができる。この結果、層間に水分を保持できるため水分閉塞性が高まるので好ましい。更に塗布後の肌の外観も向上するので好ましい。 One or more types of component (B) can be used, and 0.001 to 10% by mass is contained in the total composition, preferably 0.05 to 7% by mass, and more preferably 0.1 to 3% by mass. Is done. Within this range, after applying the emulsified composition of the present invention to the skin, the lipid layer and moisture constituted by the aforementioned component (A) and components (C) to (E) described later on the skin surface in the drying process A lamellar film with alternating layers can be formed. As a result, moisture can be retained between the layers, which is preferable since moisture blockage is enhanced. Furthermore, the appearance of the skin after application is also improved, which is preferable.
本発明で用いる成分(C)のセラミド類は、前記一般式(2)で表わされるものである。 The ceramide of component (C) used in the present invention is represented by the general formula (2).
式中、R1は、ヒドロキシル基、カルボニル基若しくはアミノ基が置換していてもよい、炭素数4〜30の、好ましくはヒドロキシル基が置換していてもよい炭素数7〜22の直鎖、分岐鎖若しくは環状の飽和若しくは不飽和の炭化水素基又は水素原子である。
Zはメチレン基、メチン基又は酸素原子のいずれかを示す。
In the formula, R 1 is a straight chain having 4 to 30 carbon atoms, preferably a hydroxyl group 7 to 22 carbon atoms which may be substituted by a hydroxyl group, a carbonyl group or an amino group, A branched or cyclic saturated or unsaturated hydrocarbon group or a hydrogen atom.
Z represents a methylene group, a methine group or an oxygen atom.
X1、X2及びX3は、各々独立して水素原子、ヒドロキシル基又はアセトキシ基を示す。X1、X2及びX3のうち0〜1個がヒドロキシル基で、残余が水素原子であるのが好ましい。Zがメチン基のとき、X1とX2のいずれか一方のみが水素原子であり、他方は存在しない。また、X4は水素原子かグリセリル基であるのが好ましい。
R2及びR3は、水素原子、ヒドロキシル基、ヒドロキシメチル基又はアセトキシメチル基を示し、好ましいR2は水素原子又はヒドロキシメチル基であり、好ましいR3は水素原子である。
X 1 , X 2 and X 3 each independently represent a hydrogen atom, a hydroxyl group or an acetoxy group. It is preferable that 0 to 1 of X 1 , X 2 and X 3 are hydroxyl groups and the remainder is a hydrogen atom. When Z is a methine group, only one of X 1 and X 2 is a hydrogen atom, and the other does not exist. X 4 is preferably a hydrogen atom or a glyceryl group.
R 2 and R 3 represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an acetoxymethyl group, preferred R 2 is a hydrogen atom or a hydroxymethyl group, and preferred R 3 is a hydrogen atom.
R4は、ヒドロキシル基、カルボキシ基又はアミノ基が置換していてもよい、主鎖にエーテル結合、エステル結合又はアミド結合を有していてもよい炭素数5〜60の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基を示す。好ましくは、ヒドロキシル基又はアミノ基が置換していてもよい炭素数5〜35の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基、又は該炭化水素基のω位に、ヒドロキシル基が置換してもよい炭素数8〜22の直鎖、分岐又は環状の飽和又は不飽和の脂肪酸がエステル結合又はアミド結合したものが挙げられる。結合する脂肪酸としては、イソステアリン酸、12−ヒドロキシステアリン酸又はリノール酸が好ましい。 R 4 is a linear, branched or branched chain having 5 to 60 carbon atoms which may have an ether bond, an ester bond or an amide bond in the main chain, which may be substituted with a hydroxyl group, a carboxy group or an amino group. A cyclic saturated or unsaturated hydrocarbon group is shown. Preferably, the hydroxyl group or amino group may be substituted a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 5 to 35 carbon atoms, or a hydroxyl group at the ω position of the hydrocarbon group In which a linear, branched, or cyclic saturated or unsaturated fatty acid having 8 to 22 carbon atoms, which may be substituted, is an ester bond or an amide bond. As the fatty acid to be bonded, isostearic acid, 12-hydroxystearic acid or linoleic acid is preferable.
R5は、水素原子を示すか、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基及びアセトキシ基から選ばれる置換基を有していてもよい総炭素数1〜30の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基である。R1が水素原子、Zが酸素原子のときR5は総炭素数10〜30の炭化水素基である。また、R1が炭化水素基のときR5は総炭素数1〜8の炭化水素基である。これらのうち、水素原子あるいは、ヒドロキシル基及びヒドロキシアルコキシ基、アルコキシ基から選ばれる1〜3個が置換していてもよい総炭素数1〜8の炭化水素基が好ましい。ここで、ヒドロキシアルコキシ基及びアルコキシ基としては炭素数1〜7のものが好ましい。 R 5 represents a hydrogen atom, or may have a substituent selected from a hydroxyl group, a hydroxyalkoxy group, an alkoxy group, and an acetoxy group. It is a saturated hydrocarbon group. When R 1 is a hydrogen atom and Z is an oxygen atom, R 5 is a hydrocarbon group having 10 to 30 carbon atoms in total. When R 1 is a hydrocarbon group, R 5 is a hydrocarbon group having 1 to 8 carbon atoms in total. Of these, a hydrogen atom, or a hydrocarbon group having 1 to 8 carbon atoms in total, which may be substituted with 1 to 3 groups selected from a hydroxyl group, a hydroxyalkoxy group, and an alkoxy group, is preferable. Here, as a hydroxy alkoxy group and an alkoxy group, a C1-C7 thing is preferable.
一般式(2)で表わされる化合物としては、次の一般式(3)又は(4)で表わされるセラミド類が好ましい。
(I)一般式(3)で表わされる化合物は、天然由来のセラミド類又は同構造の合成物であっても良い。
As the compound represented by the general formula (2), ceramides represented by the following general formula (3) or (4) are preferable.
(I) The compound represented by the general formula (3) may be a naturally-occurring ceramide or a synthetic product having the same structure.
(式中、R11はヒドロキシル基が置換していてもよい炭素数7〜19の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基を示し;Z1はメチレン基又はメチン基を示し;X5、X6、及びX7は各々独立して水素原子、ヒドロキシル基又はアセトキシ基を示し;X8は水素原子を示すか、隣接する酸素原子と一緒になってオキソ基を形成し(但し、Z1がメチン基のとき、X5とX6のいずれか一方が水素原子であり、他方は存在しない。X8がオキソ基を形成するとき、X7は存在しない。);R12はヒドロキシメチル基又はアセトキシメチル基を示し;R13は水素原子を示すか、炭素数1〜4のアルキル基を示し;R14はヒドロキシル基が置換していてもよい炭素数5〜30の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基であるか、又は該アルキル基のω末端に、ヒドロキシル基が置換していてもよい炭素数8〜22の直鎖又は分岐鎖の飽和又は不飽和の脂肪酸がエステル結合したものを示し;破線部は不飽和結合であってもよいことを示す。) (Wherein R 11 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 7 to 19 carbon atoms which may be substituted by a hydroxyl group; Z 1 represents a methylene group or a methine group; X 5 , X 6 and X 7 each independently represents a hydrogen atom, a hydroxyl group or an acetoxy group; X 8 represents a hydrogen atom or together with an adjacent oxygen atom, forms an oxo group. (However, when Z 1 is a methine group, one of X 5 and X 6 is a hydrogen atom and the other does not exist. When X 8 forms an oxo group, X 7 does not exist.); R 12 represents a hydroxymethyl group or an acetoxymethyl group; R 13 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R 14 has 5 to 30 carbon atoms which may be substituted by a hydroxyl group Whether it is a linear, branched or cyclic saturated or unsaturated hydrocarbon group Or a linear or branched saturated or unsaturated fatty acid having 8 to 22 carbon atoms which may be substituted with a hydroxyl group at the ω-terminal of the alkyl group; Indicates that it may be a bond.)
好ましくは、R11が炭素数7〜19、更に好ましくは炭素数13〜15の直鎖アルキル基;R14がヒドロキシル基が置換しても良い炭素数9〜27の直鎖アルキル基又はリノール酸がエステル結合した炭素数9〜27の直鎖アルキル基である化合物が挙げられる。また、X8は水素原子を示すか、酸素原子とともにオキソ基を形成するのが好ましい。更に、R14としては、トリコシル、1−ヒドロキシペンタデシル、1−ヒドロキシトリコシル、ヘプタデシル、1−ヒドロキシウンデシル、ω位にリノール酸がエステル結合したノナコシル基が好ましい。 Preferably, R 11 is a linear alkyl group having 7 to 19 carbon atoms, more preferably 13 to 15 carbon atoms; R 14 is a linear alkyl group having 9 to 27 carbon atoms that may be substituted by a hydroxyl group, or linoleic acid Is a straight-chain alkyl group having 9 to 27 carbon atoms with an ester bond. X 8 preferably represents a hydrogen atom or forms an oxo group together with an oxygen atom. Further, R 14 is preferably tricosyl, 1-hydroxypentadecyl, 1-hydroxytricosyl, heptadecyl, 1-hydroxyundecyl, or a nonacosyl group in which linoleic acid is ester-bonded to the ω position.
天然型セラミドの具体的な例示として、スフィンゴシン、ジヒドロスフィンゴシン、フィトスフィンゴシン又はスフィンガジエニンがアミド化されたセラミドType1〜7(例えば、J. Lipid Res., 24:759(1983)の図2、及びJ. Lipid. Res.,35:2069(1994)の図4記載のブタ及びヒトのセラミド類)が挙げられる。 Specific examples of natural ceramides include ceramides Type 1 to 7 in which sphingosine, dihydrosphingosine, phytosphingosine or sphingadienin is amidated (for example, J. Lipid Res., 24: 759 (1983), FIG. And porcine and human ceramides described in FIG. 4 of J. Lipid. Res., 35: 2069 (1994)).
更にこれらのN−アルキル体(例えばN−メチル体)も含まれる。
これらのセラミドは天然型(D(−)体)の光学活性体を用いても、非天然型(L(+)体)の光学活性体を用いても、更に天然型と非天然型の混合物を用いてもよい。上記化合物の相対立体配置は、天然型の立体配置のものでも、それ以外の非天然型の立体配置のものでも良く、また、これらの混合物によるものでもよい。これらのうち、CERAMIDE1、CERAMIDE2、CERAMIDE3、CERAMIDE5、CERAMIDE6IIの化合物(以上、INCI、8th Edition)及び次式で表わされるものが好ましい。
Furthermore, these N-alkyl bodies (for example, N-methyl body) are also included.
These ceramides may be either natural (D (−)) optically active or non-natural (L (+)) optically active, or a mixture of natural and nonnatural. May be used. The relative configuration of the above compound may be a natural configuration, a non-natural configuration other than that, or a mixture thereof. Of these, compounds of CERAMIDE1, CERAMIDE2, CERAMIDE3, CERAMIDE5, CERAMIDE6II (hereinafter referred to as INCI, 8th Edition) and those represented by the following formula are preferable.
これらは天然からの抽出物及び合成物のいずれでもよく、市販のものを用いることができる。
このような天然型セラミドの市販のものとしては、Ceramide I、Ceramide III、Ceramide IIIA、Ceramide IIIB、Ceramide IIIC、Ceramide VI(以上、コスモファーム社)、Ceramide TIC-001(高砂香料社)、CERAMIDE II(Quest International社)、DS-Ceramide VI、DS-CLA-Phytoceramide、C6-Phytoceramide、DS-ceramide Y3S(DOOSAN社)、CERAMIDE2(セダーマ社)が挙げられる。
These may be any of natural extracts and synthetic products, and commercially available products can be used.
Such commercially available natural ceramides are Ceramide I, Ceramide III, Ceramide IIIA, Ceramide IIIB, Ceramide IIIC, Ceramide VI (above, Cosmo Farm), Ceramide TIC-001 (Takasago Inc.), CERAMIDE II (Quest International), DS-Ceramide VI, DS-CLA-Phytoceramide, C6-Phytoceramide, DS-ceramide Y3S (DOOSAN), CERAMIDE2 (Cedama).
(II)一般式(4)で表わされる擬似型セラミド。 (II) A pseudo-ceramide represented by the general formula (4).
(式中、R15は、ヒドロキシル基が置換していてもよい炭素数10〜22の直鎖、分岐鎖若しくは環状の飽和若しくは不飽和の炭化水素基又は水素原子を示し;X9は水素原子、アセチル基又はグリセリル基を示し;R16はヒドロキシル基又はアミノ基が置換していてもよい炭素数5〜22の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基であるか、又は該炭化水素基のω末端に、ヒドロキシル基が置換していてもよい炭素数8〜22の直鎖又は分岐鎖の飽和又は不飽和の脂肪酸がエステル結合したものを示し;R17は水素原子を示すか、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基又はアセトキシ基が置換していてもよい総炭素数1〜30のアルキル基を示す。) (In the formula, R 15 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group or a hydrogen atom having 10 to 22 carbon atoms which may be substituted with a hydroxyl group; X 9 represents a hydrogen atom; , An acetyl group or a glyceryl group; R 16 is a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 5 to 22 carbon atoms which may be substituted with a hydroxyl group or an amino group; Or a hydrocarbon group having an ester bond with a linear or branched saturated or unsaturated fatty acid having 8 to 22 carbon atoms which may be substituted with a hydroxyl group at the ω-terminal; R 17 represents a hydrogen atom; Or a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an acetoxy group which may be substituted is an alkyl group having 1 to 30 carbon atoms in total.
R16としては、ノニル、トリデシル、ペンタデシル、ω位にリノール酸がエステル結合したウンデシル基、ω位にリノール酸がエステル結合したペンタデシル基、ω位に12−ヒドロキシステアリン酸がエステル結合したペンタデシル基、ω位にメチル分岐イソステアリン酸がアミド結合したウンデシル基が好ましい。 R 16 includes nonyl, tridecyl, pentadecyl, an undecyl group in which linoleic acid is ester-bonded to the ω-position, a pentadecyl group in which linoleic acid is ester-bonded to the ω-position, a pentadecyl group in which 12-hydroxystearic acid is ester-bonded to the ω-position, An undecyl group in which methyl branched isostearic acid is amide-bonded at the ω position is preferred.
R17は、R15が水素原子の場合は、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基又はアセトキシ基が置換していてもよい総炭素数10〜30の、好ましくは総炭素数12〜20のアルキル基であり、R15がヒドロキシル基が置換していてもよい炭素数10〜22の直鎖、分岐鎖又は環状の飽和又は不飽和の炭化水素基である場合には、水素原子を示すか、ヒドロキシル基、ヒドロキシアルコキシ基、アルコキシ基又はアセトキシ基が置換していてもよい総炭素数1〜8のアルキル基を示すものが好ましい。R17のヒドロキシアルコキシ基又はアルコキシ基としては炭素数1〜7のものが好ましい。 R 17 is an alkyl having a total carbon number of 10 to 30, preferably a total carbon number of 12 to 20, which may be substituted by a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an acetoxy group when R 15 is a hydrogen atom. When R 15 is a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 10 to 22 carbon atoms which may be substituted with a hydroxyl group, What shows a C1-C8 alkyl group which the hydroxyl group, the hydroxy alkoxy group, an alkoxy group, or an acetoxy group may substitute is preferable. As the hydroxyalkoxy group or alkoxy group for R17, those having 1 to 7 carbon atoms are preferred.
一般式(4)としては、R15がヘキサデシル基、X9が水素原子、R16がペンタデシル基、R17がヒドロキシエチル基のもの;R15がヘキサデシル基、X9が水素原子、R16がノニル基、R17がヒドロキシエチル基のもの;又はR15がヘキサデシル基、X9がグリセリル基、R16がトリデシル基、R17が3−メトキシプロピル基の擬似型セラミド類が好ましく、一般式(4)のR15がヘキサデシル基、X9が水素原子、R16がペンタデシル基、R17がヒドロキシエチル基のもの(N−(ヘキサデシロキシヒドロキシプロピル)−N−ヒドロキシエチルヘキサデカナミド)が、更に好ましい。 In general formula (4), R 15 is a hexadecyl group, X 9 is a hydrogen atom, R 16 is a pentadecyl group, R 17 is a hydroxyethyl group; R 15 is a hexadecyl group, X 9 is a hydrogen atom, and R 16 is R 16 Preferred are pseudoceramides having a nonyl group, R 17 is a hydroxyethyl group; or R 15 is a hexadecyl group, X 9 is a glyceryl group, R 16 is a tridecyl group, and R 17 is a 3-methoxypropyl group. 4) R 15 is a hexadecyl group, X 9 is a hydrogen atom, R 16 is a pentadecyl group, and R 17 is a hydroxyethyl group (N- (hexadecyloxyhydroxypropyl) -N-hydroxyethylhexadecanamide). More preferred.
成分(C)の化合物は、1種以上を用いることができ、全組成中に0.001〜15質量%含有され、好ましくは0.05〜7質量%、更に好ましくは0.5〜5質量%含有される。この範囲内であれば、本発明の乳化組成物を皮膚に塗布後、乾燥過程で皮膚表面に前述の成分(A)、(B)及び、後述する成分(D)〜(E)が構成する脂質層と水分層が交互に並ぶラメラ状皮膜を形成することができる。この結果、層間に水分を保持できる。なお、本件発明の乳化組成物中及び、塗布乾燥後形成されるラメラ状の皮膜中において、成分(C)は結晶化することがない。この結果、成分(C)は皮膚に高浸透させることが出来るので好ましい。更に、塗布後の肌の外観向上・使用感触向上につながるので好ましい。 The compound of component (C) can use 1 or more types, 0.001-15 mass% is contained in the whole composition, Preferably it is 0.05-7 mass%, More preferably, it is 0.5-5 mass. % Content. If it is in this range, after apply | coating the emulsion composition of this invention to skin, the above-mentioned component (A), (B) and the component (D)-(E) mentioned later comprise on the skin surface in the drying process. A lamellar film in which lipid layers and moisture layers are alternately arranged can be formed. As a result, moisture can be retained between the layers. In addition, a component (C) does not crystallize in the emulsion composition of this invention and the lamellar-like film | membrane formed after application | coating drying. As a result, the component (C) is preferable because it can be highly penetrated into the skin. Furthermore, it is preferable because it improves the appearance and feel of use after application.
本発明で用いる成分(D)のアニオン界面活性剤としては、例えば、ラウリン酸ナトリウム、パルミチン酸カリウム、ステアリン酸アルギニン等の炭素数12〜24の脂肪酸塩;ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等のアルキル硫酸エステル塩;ポリオキシエチレンラウリル硫酸トリエタノールアミン等のアルキルエーテル硫酸エステル塩;ラウロイルサルコシンナトリウム等のN−アシルサルコシン塩;N−ステアロイル−N−メチルタウリンナトリウム、N−ミリストイル−N−メチルタウリンナトリウム等の脂肪酸アミドスルホン酸塩;モノステアリルリン酸ナトリウム等のアルキルリン酸塩;ポリオキシエチレンオレイルエーテルリン酸ナトリウム、ポリオキシエチレンステアリルエーテルリン酸ナトリウム等のポリオキシエチレンアルキルエーテルリン酸塩;ジ−2−エチルヘキシルスルホコハク酸ナトリウム等の長鎖スルホコハク酸塩;N−ラウロイルグルタミン酸モノナトリウム、N−ステアロイル−L−グルタミン酸ナトリウム、N−ステアロイル−L−グルタミン酸アルギニン、N−ステアロイルグルタミン酸ナトリウム、N−ミリストイル−L−グルタミン酸ナトリウム等の長鎖N−アシルグルタミン酸塩などが挙げられる。 Examples of the anionic surfactant of component (D) used in the present invention include fatty acid salts having 12 to 24 carbon atoms such as sodium laurate, potassium palmitate and arginine stearate; alkyl such as sodium lauryl sulfate and potassium lauryl sulfate. Sulfate ester salt; alkyl ether sulfate ester salt such as polyoxyethylene lauryl sulfate triethanolamine; N-acyl sarcosine salt such as lauroyl sarcosine sodium; N-stearoyl-N-methyltaurine sodium, N-myristoyl-N-methyltaurine sodium Fatty acid amide sulfonates such as sodium monostearyl phosphate, etc .; Polyoxyethylene oleyl ether sodium phosphate, polyoxyethylene stearyl ether sodium phosphate, etc. Siethylene alkyl ether phosphate; long-chain sulfosuccinate such as sodium di-2-ethylhexylsulfosuccinate; monosodium N-lauroyl glutamate, sodium N-stearoyl-L-glutamate, arginine N-stearoyl-L-glutamate, N -Long-chain N-acyl glutamate such as sodium stearoyl glutamate and sodium N-myristoyl-L-glutamate.
これらのうち、炭素数12〜24の脂肪酸塩、アルキル硫酸エステル塩、アルキルエーテル硫酸エステル塩、脂肪酸アミドスルホン酸塩、アルキルリン酸塩、ポリオキシエチレンアルキルエーテルリン酸塩、長鎖N−アシルグルタミン酸塩が好ましい。
中でも、ステアロイルグルタミン酸塩、ステアロイルメチルタウリン塩、ポリオキシエチレンステアリルエーテルリン酸塩が好ましく、ステアロイルグルタミン酸塩、ステアロイルメチルタウリン塩がより好ましく、更に、ステアロイルグルタミン酸塩が好ましい。
成分(D)の塩としては、ナトリウム塩、カリウム塩、塩基性アミノ酸塩、アンモニウムから選ばれる1種以上が好ましく、乳化組成物の粘度の発現の観点からナトリウム塩、アルギニン塩から選ばれる1種以上が好ましい。
Among these, C12-24 fatty acid salt, alkyl sulfate ester salt, alkyl ether sulfate ester salt, fatty acid amide sulfonate, alkyl phosphate, polyoxyethylene alkyl ether phosphate, long-chain N-acyl glutamic acid Salts are preferred.
Among them, stearoyl glutamate, stearoyl methyl taurate, and polyoxyethylene stearyl ether phosphate are preferable, stearoyl glutamate and stearoyl methyl taurate are more preferable, and stearoyl glutamate is more preferable.
The salt of component (D) is preferably one or more selected from sodium salts, potassium salts, basic amino acid salts, and ammonium, and one selected from sodium salts and arginine salts from the viewpoint of developing the viscosity of the emulsion composition. The above is preferable.
成分(D)は酸として配合し、塩基によって中和して塩として含有されることもできる。この場合の成分(D)を中和する塩基は、塩基性アミノ酸、水酸化ナトリウム、水酸化カリウム、トリエタノールアミン、水酸化カルシウムから選ばれる1種又は2種以上が好ましく、塩基性アミノ酸は、アルギニン、リジン、ヒスチジンから選ばれる1種又は2種以上が好ましい。成分(D)を中和する塩基としては、乳化組成物の粘度の発現の観点からアルギニン、水酸化ナトリウムから選ばれる1種又は2種が好ましく、使用感等の点からアルギニンがより好ましい。 Component (D) can be blended as an acid, neutralized with a base, and contained as a salt. The base for neutralizing component (D) in this case is preferably one or more selected from basic amino acids, sodium hydroxide, potassium hydroxide, triethanolamine, and calcium hydroxide. One or more selected from arginine, lysine and histidine are preferred. As a base which neutralizes a component (D), 1 type or 2 types chosen from arginine and sodium hydroxide from a viewpoint of expression of the viscosity of an emulsion composition are preferable, and arginine is more preferable from points, such as a usability | use_condition.
成分(D)は、1種以上を用いることができ、全組成中に0.00025〜10質量%含有され、好ましくは0.05〜2質量%、更に好ましくは0.1〜1質量%含有される。この範囲内であれば、成分(A)〜(C)を乳化することができる。更に、本発明の乳化組成物を皮膚に塗布後、乾燥過程で皮膚表面に成分(A)〜(D)及び成分(E)とで構成する脂質層と水分層が交互に並ぶラメラ状皮膜を形成することができる。この結果、層間に水分を保持でき、水分保持能向上に役立つので好ましい。 One or more types of component (D) can be used, and 0.00025-10 mass% is contained in the whole composition, preferably 0.05-2 mass%, more preferably 0.1-1 mass%. Is done. If it exists in this range, component (A)-(C) can be emulsified. Furthermore, after applying the emulsified composition of the present invention to the skin, a lamellar film in which lipid layers and water layers composed of the components (A) to (D) and the component (E) are alternately arranged on the skin surface in the drying process is formed. Can be formed. As a result, moisture can be retained between the layers, which is preferable because it helps improve moisture retention.
本発明で用いる成分(E)は、アルキル変性ポリアクリル酸系ポリマー及びアルキル変性多糖類系ポリマーから選ばれる水溶性高分子である。
例えば、アクリル酸アルキル共重合体、(メタ)アクリル酸/(メタ)アクリル酸アルキル共重合体、アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレンステアリルエーテル共重合体、多糖誘導体等が挙げられる。
より具体的には、(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース、ステアロキシPGヒドロキシエチルセルローススルホン酸Na等が好ましい。
市販品としては、例えば、アクリル酸アルキル重合体として、アキュリン33(ザ・ダウ・ケミカル・カンパニー)、(メタ)アクリル酸/(メタ)アクリル酸アルキル共重合体として、ペムレンTR−1、ペムレンTR−2、カーボポールETD2020(以上、Lubrizol Advanced Materials, Inc.)等が挙げられる。また、アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレンステアリルエーテル共重合体としては、アキュリン22(ザ・ダウ・ケミカル・カンパニー)等が挙げられる。多糖誘導体としては、SPS−S−SA、ソフケアEP−S(以上、花王社)、Natrosol Plus(Hercules-Aqualon)等が挙げられる。
Component (E) used in the present invention is a water-soluble polymer selected from alkyl-modified polyacrylic acid polymers and alkyl-modified polysaccharide polymers.
Examples include alkyl acrylate copolymers, (meth) acrylic acid / (meth) acrylic acid alkyl copolymers, alkyl acrylate / alkyl methacrylate / polyoxyethylene stearyl ether copolymers, polysaccharide derivatives, and the like.
More specifically, (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / methacrylic acid steareth-20) copolymer, laureth-13PG hydroxyethyl cellulose, stearoxy PG hydroxyethyl cellulose sulfonate Na and the like are preferable. .
Commercially available products include, for example, alkyl acrylate polymers such as Aculin 33 (The Dow Chemical Company) and (meth) acrylic acid / (meth) acrylate alkyl copolymers such as Pemlen TR-1 and Pemlen TR. -2, Carbopol ETD2020 (Lubricol Advanced Materials, Inc.) and the like. Further, examples of the alkyl acrylate / alkyl methacrylate / polyoxyethylene stearyl ether copolymer include Aculin 22 (The Dow Chemical Company). Examples of polysaccharide derivatives include SPS-S-SA, Sofcare EP-S (above, Kao Corporation), Natrosol Plus (Hercules-Aqualon) and the like.
成分(E)は、1種以上を用いることができ、全組成中に0.001〜6質量%含有され、好ましくは0.05〜5質量%、更に好ましくは0.1〜3質量%含有される。この範囲内であれば、本発明の乳化組成物の保存安定性を向上させることができる。更に、成分(A)〜(D)で構成される脂質混合物の結晶化を抑制することがでる。この結果、本発明の乳化組成物を塗布後、乾燥過程で皮膚表面に形成されるラメラ状の皮膜に柔軟性を付与することができる。この結果、水分保持能/使用感触向上/塗布後の肌の外観向上に役立つので好ましい。 One or more types of component (E) can be used, and 0.001 to 6% by mass is contained in the total composition, preferably 0.05 to 5% by mass, more preferably 0.1 to 3% by mass. Is done. Within this range, the storage stability of the emulsion composition of the present invention can be improved. Furthermore, crystallization of the lipid mixture composed of the components (A) to (D) can be suppressed. As a result, after applying the emulsified composition of the present invention, flexibility can be imparted to the lamellar film formed on the skin surface in the drying process. As a result, it is preferable because it is useful for improving the water retention ability / use feeling / appearance of the skin after application.
本発明において、成分(F)の水は、各成分の残部をなし、全組成中に49〜85質量%、更に55〜80質量%含有されるのが好ましい。 In this invention, the water of a component (F) comprises the remainder of each component, and it is preferable that 49-85 mass% and also 55-80 mass% are contained in the whole composition.
本発明においては、成分(A)、(B)、(C)、(D)及び(E)の質量割合が、(E)/((A)+(B)+(C))=0.0025〜50、更に0.01〜3、特に0.1〜1.5であるのが、高粘度で弾性的な液性が得られる点で好ましい。この結果、皮膚に塗布した際、高い塗布感を感じさせ、良好な使用感を付与することができる。
また、(E)/(D)=0.025〜100、更に0.14〜7.5、特に1.2〜6であるのが、柔軟性及び弾性を有する被膜を得るために好ましい。
In the present invention, the mass ratio of the components (A), (B), (C), (D) and (E) is (E) / ((A) + (B) + (C)) = 0. It is preferably from 0025 to 50, more preferably from 0.01 to 3, and particularly preferably from 0.1 to 1.5 in that a high viscosity and elastic liquid property can be obtained. As a result, when applied to the skin, a high feeling of application can be felt and a good feeling of use can be imparted.
Further, (E) / (D) = 0.025 to 100, more preferably 0.14 to 7.5, particularly 1.2 to 6 is preferable in order to obtain a film having flexibility and elasticity.
本発明においては、前記成分のそれぞれの好ましい成分、及び好ましい含有量を組み合わせるのが、より好ましい。 In the present invention, it is more preferable to combine the preferred components and the preferred contents of the components.
更に、本発明の乳化組成物においては、
成分(A)がモノベヘン酸グリセリル又はモノセチルグリセリルエーテル、
成分(B)がセタノール又はステアリルアルコール、
成分(C)が一般式(1)で表される化合物、
成分(D)がステアロイルグルタミン酸塩、ステアロイルメチルタウリン塩又はポリオキシエチレンステアリルエーテルリン酸塩、
成分(E)が(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース又はステアロキシPGヒドロキシエチルセルローススルホン酸Na、
成分(F)が水であるのが好ましい。
Furthermore, in the emulsion composition of the present invention,
Component (A) is glyceryl monobehenate or monocetyl glyceryl ether,
Component (B) is cetanol or stearyl alcohol,
A compound in which component (C) is represented by formula (1);
Component (D) is stearoyl glutamate, stearoyl methyl taurate or polyoxyethylene stearyl ether phosphate,
Component (E) is an (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / stealeth methacrylate-20) copolymer, laureth-13PG hydroxyethyl cellulose or stearoxy PG hydroxyethyl cellulose sulfonate Na,
It is preferred that component (F) is water.
更に、本発明の乳化組成物においては、
成分(A)がモノベヘン酸グリセリル、
成分(B)がセタノール、
成分(C)が一般式(1)で表される化合物、
成分(D)がステアロイルグルタミン酸塩、
成分(E)が(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース又はステアロキシPGヒドロキシエチルセルローススルホン酸Na、
成分(F)が水であるのが好ましい。
Furthermore, in the emulsion composition of the present invention,
Component (A) is glyceryl monobehenate,
Component (B) is cetanol,
A compound in which component (C) is represented by formula (1);
Component (D) is stearoyl glutamate,
Component (E) is an (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / stealeth methacrylate-20) copolymer, laureth-13PG hydroxyethyl cellulose or stearoxy PG hydroxyethyl cellulose sulfonate Na,
It is preferred that component (F) is water.
本発明においては、成分(A)〜(D)で、乳化物の脂質を形成する。これらは、乾燥すると、結晶化が起こり、硬くもろい皮膜を形成し、保湿性の高い皮膜は得られない。しかし、更に成分(E)を含有することにより、脂質の結晶化が抑制され、水分を多量に含有し、脂質層と水層とが交互に並ぶラメラ状の柔軟な皮膜が形成されることがわかった。特に、成分(B)にセタノールを使用すると皮膜の柔軟性が増し、肌の見た目及び感触の滑らかさが向上する。さらに、皮膚塗布剤の製造のための本発明の乳化組成物の使用、皮膚の水分保持剤の製造のための本発明の乳化組成物の使用、及び皮膚への塗布膜形成剤の製造のための本発明の乳化組成物の使用を提供することができる。 In the present invention, components (A) to (D) form an emulsion lipid. When these are dried, crystallization occurs, forming a hard and brittle film, and a film with high moisture retention cannot be obtained. However, by further containing the component (E), lipid crystallization is suppressed, and a lamellar flexible film containing a large amount of water and alternately arranging lipid layers and water layers may be formed. all right. In particular, when cetanol is used as the component (B), the flexibility of the film increases and the smoothness of the appearance and feel of the skin is improved. Further, the use of the emulsified composition of the present invention for the manufacture of a skin coating agent, the use of the emulsified composition of the present invention for the manufacture of a skin moisture retaining agent, and the manufacture of a coating film forming agent on the skin The use of the emulsified composition of the present invention can be provided.
本発明の乳化組成物は、更に、成分(B)及び(C)以外の油性成分を含有することができる。例えば、流動パラフィン、スクワラン、ワセリン等の炭化水素油;セチルジメチルブチルエーテル、エチレングリコールジオクチルエーテル、グリセロールモノオレイルエーテル等のエーテル油;ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、アジピン酸ジ−2−エチルヘキシル、ジカプリン酸ネオペンチルグリコール、トリオクタノイン等のエステル油;ステアリン酸、ベヘン酸、イソミリスチン酸等の高級脂肪酸;オリーブ油等の植物油;ジメチルポリシロキサン、環状ジメチルポリシロキサン、メチルフェニルポリシロキサン、アミノ変性シリコーン、カルボキシ変性シリコーン、アルコール変性シリコーン、アルキル変性シリコーン、ポリエーテル変性シリコーン、フッ素変性シリコーン等のシリコーン油;パーフルオロアルキルエチルリン酸、パーフルオロアルキルポリオキシエチレンリン酸、パーフルオロポリエーテル、ポリテトラフルオロエチレン等のフッ素系油などが挙げられる。これらの油性成分は、全組成中に0〜20質量%含有されるのが好ましい。 The emulsion composition of the present invention can further contain an oily component other than the components (B) and (C). For example, hydrocarbon oils such as liquid paraffin, squalane and petrolatum; ether oils such as cetyldimethylbutyl ether, ethylene glycol dioctyl ether and glycerol monooleyl ether; octyldodecyl myristate, isopropyl palmitate, butyl stearate, di-2 adipate -Ester oils such as ethylhexyl, neopentyl glycol dicaprate and trioctanoin; higher fatty acids such as stearic acid, behenic acid and isomyristinic acid; vegetable oils such as olive oil; dimethylpolysiloxane, cyclic dimethylpolysiloxane, methylphenylpolysiloxane, Amino-modified silicone, carboxy-modified silicone, alcohol-modified silicone, alkyl-modified silicone, polyether-modified silicone, fluorine-modified silicone, etc. Corn oil; perfluoroalkylethyl phosphoric acid, perfluoroalkyl polyoxyethylene phosphoric acid, a perfluoropolyether, such as fluorine-based oils such as polytetrafluoroethylene. These oil components are preferably contained in the total composition in an amount of 0 to 20% by mass.
また、本発明の乳化組成物は、通常の化粧料に用いられる有効成分や添加剤、例えば、アスコルビン酸、ニコチン酸アミド、ニコチン酸等の水溶性ビタミン類;オウバクエキス、カンゾウエキス、アロエエキス、スギナエキス、茶エキス、キューカンバーエキス、チョウジエキス、ニンジンエキス、ハマメリス抽出液、プラセンタエキス、海藻エキス、マロニエエキス、ユズエキス、アスナロエキス、ローヤルゼリーエキス、ユーカリエキス、アスナロ抽出液等の動・植物抽出液;水酸化カリウム、水酸化ナトリウム、トリエタノールアミン、炭酸ナトリウム等の塩基;クエン酸、酒石酸、乳酸、リン酸、コハク酸、アジピン酸等の酸などを含有することもできる。 The emulsified composition of the present invention is an active ingredient or additive used in normal cosmetics, for example, water-soluble vitamins such as ascorbic acid, nicotinic acid amide, and nicotinic acid; buckwheat extract, licorice extract, aloe extract, Animal and plant extracts such as horse chestnut extract, tea extract, cucumber extract, clove extract, carrot extract, cranberry extract, placenta extract, seaweed extract, maronier extract, yuzu extract, asunaro extract, royal jelly extract, eucalyptus extract, asunaro extract; Bases such as potassium hydroxide, sodium hydroxide, triethanolamine and sodium carbonate; acids such as citric acid, tartaric acid, lactic acid, phosphoric acid, succinic acid and adipic acid can also be contained.
本発明の乳化組成物の製造方法は、成分(A)〜(D)及び成分(F)の一部(F1)を含む水相Iを混合して乳化し、冷却する工程1の後、成分(E)及び成分(F)の残部(F2)を含む水相成分(水相II)を更に混合する工程を備えることが好ましい。この方法によれば、α−ゲル構造を形成させた後にポリマーを相互作用させることで、広い温度範囲において、安定性に優れた乳化物が得られるので好ましい。 The method for producing an emulsified composition of the present invention comprises the steps (1) of (1) in which the aqueous phase I containing the components (A) to (D) and a part (F1) of the component (F) is mixed and emulsified and cooled. It is preferable to further comprise a step of further mixing the aqueous phase component (aqueous phase II) containing (E) and the remainder (F2) of component (F). This method is preferable because an emulsion having excellent stability can be obtained in a wide temperature range by allowing the polymer to interact after forming the α-gel structure.
工程1は、α−ゲル構造を形成させる工程であって、以下の工程1A、1B、1C及び1Dの4つの製造工程から選ばれる工程が好ましい。製造性の点からは、未中和の成分(D)を塩基により中和する工程を備える工程1A及び工程1Cから選ばれる工程が好ましく、粘度発現の観点からは、油相に成分(D)を混合する工程1A及び工程1Bから選ばれる工程が好ましい。以上のように、工程1は、工程1A、工程1B及び工程1Cから選ばれる工程を備えることが好ましく、工程1A又は工程1Bを備えることがより好ましく、工程1Aを備えることがさらに好ましい。 Step 1 is a step of forming an α-gel structure, and a step selected from the following four manufacturing steps 1A, 1B, 1C, and 1D is preferable. From the viewpoint of manufacturability, a step selected from Step 1A and Step 1C comprising a step of neutralizing an unneutralized component (D) with a base is preferable. A step selected from Step 1A and Step 1B in which is mixed is preferable. As described above, step 1 preferably includes a step selected from step 1A, step 1B, and step 1C, more preferably includes step 1A or step 1B, and further preferably includes step 1A.
工程1A:成分(A)、(B)、(C)及び未中和の成分(D)を含む油相の混合成分を得る工程と、当該油相に成分(F)の一部(F1)及び塩基を含む水相Iを混合して乳化し、冷却する工程を備
える工程。
工程1B:成分(A)、(B)、(C)及び成分(D)の塩を含む油相の混合成分を得る工程と、当該油相に成分(F)の一部(F1)を含む水相Iを混合して乳化し、冷却する工程を備える工程。
工程1C:成分(A)、(B)及び(C)を含む油相の混合成分を得る工程と、当該油相に未中和の成分(D)、成分(F)の一部(F1)及び塩基を含む水相Iを混合して乳化し、冷却する工程。
工程1D:成分(A)、(B)及び(C)を含む油相の混合成分を得る工程と、当該油相に成分(D)の塩及び成分(F)の一部(F1)を含む水相Iを混合して乳化し、冷却する工程を備える工程。
Step 1A: A step of obtaining a mixed component of an oil phase containing components (A), (B), (C) and an unneutralized component (D), and a part of the component (F) (F1) in the oil phase And a step of mixing and emulsifying the aqueous phase I containing the base and cooling.
Step 1B: A step of obtaining a mixed component of the oil phase containing the salts of components (A), (B), (C) and component (D), and a part (F1) of component (F) is included in the oil phase A step comprising mixing, emulsifying and cooling the aqueous phase I.
Step 1C: a step of obtaining a mixed component of an oil phase containing components (A), (B) and (C), an unneutralized component (D) in the oil phase, a part of component (F) (F1) And the aqueous phase I containing the base is mixed and emulsified and cooled.
Step 1D: A step of obtaining a mixed component of an oil phase containing components (A), (B) and (C), and a salt of component (D) and a part (F1) of component (F) are included in the oil phase A step comprising mixing, emulsifying and cooling the aqueous phase I.
これらの方法においては、成分(F)の水を、(F1)と(F2)に分けて添加・混合するが、その質量割合は、(F1)/(F2)=0.1〜9、更に0.25〜4であるのが好ましい。 In these methods, water of component (F) is added and mixed separately in (F1) and (F2), and the mass ratio is (F1) / (F2) = 0.1-9, It is preferable that it is 0.25-4.
得られる乳化組成物は、α−ゲル(α型結晶)であり、結晶(γ型結晶)の析出が抑制される。α−ゲルは、X線による構造解析により、確認することができる。α型構造は六方晶系のことであり、親油基が親水基層の面に対して直角に配向しており、Bragg角21〜23°付近に鋭い一本の回折ピークが現れるのが特徴である。 The obtained emulsified composition is α-gel (α-type crystal), and precipitation of crystals (γ-type crystal) is suppressed. The α-gel can be confirmed by structural analysis by X-ray. The α-type structure is a hexagonal system, and the lipophilic group is oriented at right angles to the surface of the hydrophilic base layer, and a sharp diffraction peak appears at a Bragg angle of 21-23 °. is there.
また、乳化組成物は、25℃における粘度が10〜8000dPa・s、500〜1500dPa・sであるのがより好ましく、更に1500〜5000dPa・sであるのが好ましい。本発明の乳化組成物は、前記成分を組み合わせることにより、このように高粘度で弾性的な液性として得ることができる。
なお、本発明において、粘度は、25℃において、B8R型回転粘度計(ロータC又はD、5r/min、1分間測定)により、測定したものである。
The emulsified composition preferably has a viscosity at 25 ° C. of 10 to 8000 dPa · s, 500 to 1500 dPa · s, and more preferably 1500 to 5000 dPa · s. The emulsified composition of the present invention can be obtained as a highly viscous and elastic liquid by combining the above components.
In the present invention, the viscosity is measured at 25 ° C. with a B8R type rotational viscometer (rotor C or D, 5 r / min, measured for 1 minute).
また、得られる乳化組成物は、水中油型乳化組成物であり、例えば、化粧水、乳液、クリーム、ジェル等の化粧料や、皮膚外用剤として好適である。上述した実施の形態に関し、本発明は、さらに以下の乳化組成物の使用方法、用途を開示する。 Moreover, the obtained emulsion composition is an oil-in-water emulsion composition, and is suitable, for example, as cosmetics such as skin lotion, emulsion, cream, and gel, and as a skin external preparation. In relation to the above-described embodiment, the present invention further discloses a method for using the emulsified composition described below and its application.
皮膚への塗布膜形成剤の製造のための、成分(A)、(B)、(C)、(D)、(E)及び(F)を含有する乳化組成物の使用。
皮膚外用剤の製造のための、成分(A)、(B)、(C)、(D)、(E)及び(F)を含有する乳化組成物の使用。
成分(A)、(B)、(C)、(D)、(E)及び(F)を含有する、皮膚への塗布膜形成用水中油型乳化組成物。
Use of an emulsified composition containing components (A), (B), (C), (D), (E) and (F) for the production of a coating film forming agent on the skin.
Use of the emulsion composition containing component (A), (B), (C), (D), (E) and (F) for manufacture of a skin external preparation.
An oil-in-water emulsion composition for forming a coating film on the skin, comprising components (A), (B), (C), (D), (E) and (F).
実施例1〜10及び比較例1〜7
表1及び表2に示す組成の水中油型乳化組成物を製造し、粘度及び残存水分量の測定を行うとともに、皮膜について、SAXSによるラメラ構造の確認及びSEMによる表面状態の観察を行った。また、潤いの持続性、塗布後の肌の感触及び外観を官能評価した。結果を表1及び表2に併せて示す。
Examples 1-10 and Comparative Examples 1-7
The oil-in-water emulsion compositions having the compositions shown in Tables 1 and 2 were produced, and the viscosity and the residual water content were measured. The film was confirmed for the lamellar structure by SAXS and observed for the surface state by SEM. In addition, sensory evaluation was made on the persistence of moisture, the feel and appearance of the skin after application. The results are shown in Table 1 and Table 2 together.
(製造方法)
第I相の成分を、80〜90℃で加熱混合し、これに、プロペラ攪拌下(300rpm)、80〜90℃に加熱した第II相の成分を加え、ホモミキサーにて7000rpm、10分間の条件でせん断を加えながら乳化し、α−ゲルを形成させた。25℃まで徐々に冷却した後、第III相の成分を加え、水中油型乳化組成物を得た。
(Production method)
The ingredients of phase I were heated and mixed at 80 to 90 ° C., and the ingredients of phase II heated to 80 to 90 ° C. were added to the mixture while stirring with a propeller (300 rpm). The mixture was emulsified under shearing conditions to form an α-gel. After gradually cooling to 25 ° C., the phase III component was added to obtain an oil-in-water emulsion composition.
(評価方法)
(1)粘度:
25℃において、B8R型回転粘度計(ロータC又はD、5r/min、1分間測定)により、測定した。
(Evaluation method)
(1) Viscosity:
At 25 ° C., it was measured with a B8R type rotational viscometer (rotor C or D, 5 r / min, measured for 1 minute).
(2)残存水分量:
6×6cmの金属トレーに、水中油型乳化組成物1gを一定厚みで均一に広げ、20℃、湿度40%の恒温恒湿下で、質量変化を時間に対してプロットする。経時でラメラ皮膜が形成することにより、その後質量変化が極めて小さくなる。質量が一定になった24時間後の残存水分量を求め、製剤中の固形分に対する水分量を、以下の式で求めた。固形分には、成分(A)〜(E)全ての成分を含む。
(2) Residual moisture content:
1 g of an oil-in-water emulsion composition is spread uniformly on a 6 × 6 cm metal tray at a constant thickness, and mass change is plotted against time under constant temperature and humidity of 20 ° C. and humidity of 40%. By forming a lamellar film over time, the mass change thereafter becomes extremely small. The residual water content 24 hours after the mass became constant was determined, and the water content relative to the solid content in the preparation was determined by the following formula. The solid content includes all components (A) to (E).
(3)SAXSによるラメラ構造の確認:
人工皮革サプラーレ(登録商標)に、水中油型乳化組成物を0.001g/cm2で均一に伸ばして1日乾燥させた後、皮膜表面の状態を、Nano-viewer、λCuKα=1.54Å、30分照射、カメラ長649.5mm、2θ=0.2〜5°の範囲で測定した。
(3) Confirmation of lamellar structure by SAXS:
After artificially extending the oil-in-water emulsion composition at 0.001 g / cm 2 and drying it for 1 day on an artificial leather Saplare (registered trademark), the state of the film surface was changed to Nano-viewer, λCuKα = 1.54 mm, Measurement was performed within 30 minutes of irradiation, camera length of 649.5 mm, and 2θ = 0.2 to 5 °.
(4)SEMによる皮膜の表面状態の観察:
人工皮革サプラーレ(登録商標)に、水中油型乳化組成物を0.001g/cm2で均一に伸ばして1日乾燥させた後、皮膜表面の状態を、SEM(走査型電子顕微鏡)により、倍率50倍で観察した。結果を以下の基準で示した。
○;皮丘・皮溝の境界部分が滑らか。
△;皮丘・皮溝の境界部分がめくれ上がっている。
×;皮膜を形成していない。
(4) Observation of the surface state of the film by SEM:
After artificially spreading an oil-in-water emulsified composition at 0.001 g / cm 2 on an artificial leather Saplare (registered trademark) and drying it for one day, the state of the film surface was magnified by SEM (scanning electron microscope). Observed at 50 times. The results are shown by the following criteria.
○: The boundary between the skin and the skin groove is smooth.
Δ: The boundary part of the skin hill / skin groove is turned up.
X: No film was formed.
(5)潤いの持続性、塗布後の肌の感触(滑らかさ)及び外観(見た目の滑らかさ):
12名の専門パネラーが、各水中油型乳化組成物0.4〜0.6gを顔に塗布した直後の「肌の感触の滑らかさ」及び「肌の見た目の滑らかさ」、更に塗布10時間経過後の「潤いの持続性」を官能評価した。結果を、「良好である」と評価したパネラーの人数で示した。
(5) Persistence of moisture, skin feel after application (smoothness) and appearance (smooth appearance):
Twelve professional panelists applied “smooth skin feel” and “smooth skin appearance” immediately after 0.4 to 0.6 g of each oil-in-water emulsion composition was applied to the face, and 10 hours of application. The sensory evaluation of “sustainability of moisture” after the lapse was made. The results are shown as the number of panelists rated as “good”.
実施例11〜29及び比較例8〜9
実施例1〜10と同様にして、表3〜表6に示す組成の水中油型乳化組成物を製造し、粘度及び残存水分量の測定を行うとともに、皮膜について、SAXSによるラメラ構造の確認及びSEMによる表面状態の観察を行った。また、潤いの持続性、塗布後の肌の感触及び外観を評価した。結果を表3〜表6に併せて示す。
Examples 11-29 and Comparative Examples 8-9
In the same manner as in Examples 1 to 10, oil-in-water emulsion compositions having the compositions shown in Tables 3 to 6 were produced, the viscosity and the residual water content were measured, and the film was confirmed for the lamellar structure by SAXS and The surface state was observed by SEM. Moreover, the persistence of moisture, the feeling of the skin after application | coating, and the external appearance were evaluated. The results are shown in Tables 3 to 6.
実施例1、30〜32
実施例1〜10と同様にして、表7に示す組成の水中油型乳化組成物を製造し、粘度及び残存水分量の測定を行うとともに、皮膜について、SAXSによるラメラ構造の確認及びSEMによる表面状態の観察を行った。また、潤いの持続性、塗布後の肌の感触及び外観を評価した。結果を表7に併せて示す。
Example 1, 30-32
In the same manner as in Examples 1 to 10, an oil-in-water emulsion composition having the composition shown in Table 7 was produced, and the viscosity and residual water content were measured. The film was checked for lamella structure by SAXS and surface by SEM. The state was observed. Moreover, the persistence of moisture, the feeling of the skin after application | coating, and the external appearance were evaluated. The results are also shown in Table 7.
実施例1、30は、製造工程1A、実施例31は製造工程1C、実施例32は製造工程1Dにより製造した。油相に未中和の成分(D)を配合して製造工程1Aにより製造した実施例1及び実施例30は、塗布後の肌感触の滑らかさの評価が高く、セラミドの結晶析出が抑制されラメラ構造が確認され、保湿効果が高い結果が得られ、高い粘度が得られている。 Examples 1 and 30 were manufactured by manufacturing process 1A, Example 31 was manufactured by manufacturing process 1C, and Example 32 was manufactured by manufacturing process 1D. Example 1 and Example 30 produced by blending the non-neutralized component (D) in the oil phase and produced by the production process 1A have high evaluation of the smoothness of the skin feel after application, and the crystallization of ceramide is suppressed. A lamella structure is confirmed, a result with a high moisturizing effect is obtained, and a high viscosity is obtained.
Claims (13)
(A)次の一般式(1)
で表される化合物 0.001〜10質量%、
(B)炭素数14〜22の高級アルコール及びステロール類から選ばれる1種以上の化合物 0.001〜10質量%、
(C)一般式(2):
(D)アニオン界面活性剤 0.00025〜10質量%、
(F1)水を含む水相I
を混合して乳化し、冷却する工程1の後に、
(E)アルキル変性ポリアクリル酸系ビニルポリマー及びアルキル変性多糖類系ポリマーから選ばれる水溶性高分子 0.001〜6質量%、及び
(F2)水を含む水相IIをさらに混合する工程2
を備える乳化組成物の製造方法。 The following components (A), (B), (C), (D) and (F1):
(A) The following general formula (1)
0.001 to 10% by mass of a compound represented by
(B) one or more compounds selected from higher alcohols having 14 to 22 carbon atoms and sterols 0.001 to 10% by mass,
(C) General formula (2):
(D) Anionic surfactant 0.00025-10 mass%,
(F1) Water phase I containing water
Are mixed, emulsified, and cooled, after step 1,
(E) Step 2 of further mixing water-soluble polymer 0.001 to 6% by mass selected from alkyl-modified polyacrylic acid vinyl polymer and alkyl-modified polysaccharide polymer, and (F2) water phase II containing water
A method for producing an emulsified composition.
又は成分(A)、(B)、(C)及び成分(D)の塩を含む油相の混合成分を得る工程と、当該油相に(F1)を含む水相Iを混合して乳化し、冷却する工程を備える工程1Bである請求項1記載の乳化組成物の製造方法。 Step 1 is a step of obtaining a mixed component of an oil phase containing components (A), (B), (C) and an unneutralized component (D), and an aqueous phase containing (F1) and a base in the oil phase. Step 1A comprising a step of mixing I, emulsifying and cooling.
Or the process of obtaining the mixing component of the oil phase containing the salt of component (A), (B), (C) and component (D), and the water phase I containing (F1) in the said oil phase are mixed and emulsified. The method for producing an emulsified composition according to claim 1, wherein the method is Step 1B including a step of cooling.
(A)モノベヘン酸グリセリル又はモノセチルグリセリルエーテル 0.001〜10質量%、
(B)セタノール又はステアリルアルコール 0.001〜10質量%、
(C)一般式(2)で表されるセラミド類 0.001〜15質量%、
(D)ステアロイルグルタミン酸塩、ステアロイルメチルタウリン塩又はポリオキシエチレンステアリルエーテルリン酸塩 0.00025〜10質量%、
(E)(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース又はステアロキシPGヒドロキシエチルセルローススルホン酸Na 0.001〜6質量%、
(F)水
を含有する乳化組成物。 The following components (A), (B), (C), (D), (E) and (F):
(A) glyceryl monobehenate or monocetyl glyceryl ether 0.001 to 10% by mass,
(B) cetanol or stearyl alcohol 0.001 to 10% by mass,
(C) Ceramides represented by the general formula (2) 0.001 to 15% by mass,
(D) stearoyl glutamate, stearoyl methyl taurate or polyoxyethylene stearyl ether phosphate 0.00025-10 mass%,
(E) (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / steareth methacrylate-20) copolymer, laureth-13PG hydroxyethyl cellulose or stearoxy PG hydroxyethyl cellulose sulfonate 0.001-6 mass %,
(F) An emulsified composition containing water.
成分(B)がセタノール、
成分(C)が一般式(3)又は一般式(4)で表されるセラミド類、
成分(D)がステアロイルグルタミン酸塩、
成分(E)が(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、ラウレス−13PGヒドロキシエチルセルロース又はステアロキシPGヒドロキシエチルセルローススルホン酸Na、
成分(F)が水である請求項9記載の乳化組成物。 Component (A) is glyceryl monobehenate,
Component (B) is cetanol,
Ceramides in which component (C) is represented by general formula (3) or general formula (4),
Component (D) is stearoyl glutamate,
Component (E) is an (acrylic acid / alkyl acrylate (C10-30)) copolymer, (alkyl acrylate / stealeth methacrylate-20) copolymer, laureth-13PG hydroxyethyl cellulose or stearoxy PG hydroxyethyl cellulose sulfonate Na,
The emulsified composition according to claim 9, wherein the component (F) is water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012082773A JP5941732B2 (en) | 2011-03-31 | 2012-03-30 | Emulsified composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011078500 | 2011-03-31 | ||
JP2011078500 | 2011-03-31 | ||
JP2012082773A JP5941732B2 (en) | 2011-03-31 | 2012-03-30 | Emulsified composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012214469A true JP2012214469A (en) | 2012-11-08 |
JP5941732B2 JP5941732B2 (en) | 2016-06-29 |
Family
ID=46984169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012082773A Active JP5941732B2 (en) | 2011-03-31 | 2012-03-30 | Emulsified composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5941732B2 (en) |
CN (1) | CN102727392A (en) |
TW (1) | TWI618546B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014108954A (en) * | 2012-12-03 | 2014-06-12 | Kao Corp | Emulsified cosmetic |
JP2015124210A (en) * | 2013-12-27 | 2015-07-06 | 花王株式会社 | Cosmetic |
US9339448B2 (en) | 2011-08-09 | 2016-05-17 | Kao Corporation | Emulsion composition |
JP2016222598A (en) * | 2015-05-29 | 2016-12-28 | 花王株式会社 | Skin Cosmetic |
JP6469286B1 (en) * | 2018-06-20 | 2019-02-13 | 高級アルコール工業株式会社 | Novel composite and emulsion composition |
JP2019196311A (en) * | 2018-04-16 | 2019-11-14 | ロレアル | Composition in form of o/w type |
JP2020200283A (en) * | 2019-06-11 | 2020-12-17 | 花王株式会社 | Sheet-like cosmetics |
JP2021001119A (en) * | 2019-06-19 | 2021-01-07 | 株式会社 資生堂 | Oil-in-water type cream cosmetic |
JP2021080233A (en) * | 2019-11-22 | 2021-05-27 | 花王株式会社 | Emulsion composition |
WO2022071574A1 (en) | 2020-10-02 | 2022-04-07 | 花王株式会社 | Carbonated aerosol for topical use |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107007480B (en) * | 2015-11-30 | 2021-08-17 | 富士胶片株式会社 | Gel-like oil-in-water emulsion composition, external skin preparation, and method for producing oil-in-water emulsion composition |
KR102336467B1 (en) * | 2018-03-30 | 2021-12-07 | 가부시키가이샤 만다무 | gel cosmetics |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004107227A (en) * | 2002-09-13 | 2004-04-08 | Kao Corp | Skin cosmetic |
JP2005179241A (en) * | 2003-12-18 | 2005-07-07 | Nikko Chemical Co Ltd | Emulsifier composition for oil-in-water type use, and cosmetic containing the same |
JP2006312622A (en) * | 2005-04-06 | 2006-11-16 | Kao Corp | Oil-in-water type emulsion and method for producing the same |
JP2007022997A (en) * | 2005-07-21 | 2007-02-01 | Kao Corp | Emulsified composition |
JP2007063145A (en) * | 2005-08-29 | 2007-03-15 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2007169185A (en) * | 2005-12-20 | 2007-07-05 | Kao Corp | Oil-in-water type emulsion cosmetic |
JP2008137956A (en) * | 2006-12-04 | 2008-06-19 | Kao Corp | Cosmetic |
JP2011016768A (en) * | 2009-07-10 | 2011-01-27 | Kao Corp | Method for producing cosmetic |
JP2011032266A (en) * | 2009-07-06 | 2011-02-17 | Kao Corp | Emulsified composition |
JP2011032265A (en) * | 2009-07-06 | 2011-02-17 | Kao Corp | Emulsified composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000256188A (en) * | 1999-03-10 | 2000-09-19 | Nikko Chemical Co Ltd | Emulsifier composition |
TW200416045A (en) * | 2002-12-27 | 2004-09-01 | Kao Corp | Oil-in-water emulsion composition and manufacturing method thereof |
JP5063064B2 (en) * | 2006-09-26 | 2012-10-31 | 花王株式会社 | Ceramide lipid dispersion |
JP2008208117A (en) * | 2007-01-30 | 2008-09-11 | Kao Corp | Aqueous external preparation for scalp |
EP2452668B1 (en) * | 2009-07-06 | 2018-10-03 | Kao Corporation | Emulsified composition |
-
2012
- 2012-03-28 CN CN2012100863242A patent/CN102727392A/en active Pending
- 2012-03-30 JP JP2012082773A patent/JP5941732B2/en active Active
- 2012-03-30 TW TW101111543A patent/TWI618546B/en active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004107227A (en) * | 2002-09-13 | 2004-04-08 | Kao Corp | Skin cosmetic |
JP2005179241A (en) * | 2003-12-18 | 2005-07-07 | Nikko Chemical Co Ltd | Emulsifier composition for oil-in-water type use, and cosmetic containing the same |
JP2006312622A (en) * | 2005-04-06 | 2006-11-16 | Kao Corp | Oil-in-water type emulsion and method for producing the same |
JP2007022997A (en) * | 2005-07-21 | 2007-02-01 | Kao Corp | Emulsified composition |
JP2007063145A (en) * | 2005-08-29 | 2007-03-15 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2007169185A (en) * | 2005-12-20 | 2007-07-05 | Kao Corp | Oil-in-water type emulsion cosmetic |
JP2008137956A (en) * | 2006-12-04 | 2008-06-19 | Kao Corp | Cosmetic |
JP2011032266A (en) * | 2009-07-06 | 2011-02-17 | Kao Corp | Emulsified composition |
JP2011032265A (en) * | 2009-07-06 | 2011-02-17 | Kao Corp | Emulsified composition |
JP2011016768A (en) * | 2009-07-10 | 2011-01-27 | Kao Corp | Method for producing cosmetic |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9339448B2 (en) | 2011-08-09 | 2016-05-17 | Kao Corporation | Emulsion composition |
JP2014108954A (en) * | 2012-12-03 | 2014-06-12 | Kao Corp | Emulsified cosmetic |
JP2015124210A (en) * | 2013-12-27 | 2015-07-06 | 花王株式会社 | Cosmetic |
JP2016222598A (en) * | 2015-05-29 | 2016-12-28 | 花王株式会社 | Skin Cosmetic |
JP2019196311A (en) * | 2018-04-16 | 2019-11-14 | ロレアル | Composition in form of o/w type |
WO2019244674A1 (en) * | 2018-06-20 | 2019-12-26 | 高級アルコール工業株式会社 | Novel composite and emulsion composition |
JP6469286B1 (en) * | 2018-06-20 | 2019-02-13 | 高級アルコール工業株式会社 | Novel composite and emulsion composition |
JP2019218301A (en) * | 2018-06-20 | 2019-12-26 | 高級アルコール工業株式会社 | Novel complex and emulsion composition |
JP2020200283A (en) * | 2019-06-11 | 2020-12-17 | 花王株式会社 | Sheet-like cosmetics |
JP2021001119A (en) * | 2019-06-19 | 2021-01-07 | 株式会社 資生堂 | Oil-in-water type cream cosmetic |
JP7395267B2 (en) | 2019-06-19 | 2023-12-11 | 株式会社 資生堂 | oil-in-water cream cosmetics |
JP2021080233A (en) * | 2019-11-22 | 2021-05-27 | 花王株式会社 | Emulsion composition |
JP7478534B2 (en) | 2019-11-22 | 2024-05-07 | 花王株式会社 | Emulsion composition |
WO2022071574A1 (en) | 2020-10-02 | 2022-04-07 | 花王株式会社 | Carbonated aerosol for topical use |
Also Published As
Publication number | Publication date |
---|---|
TWI618546B (en) | 2018-03-21 |
CN102727392A (en) | 2012-10-17 |
JP5941732B2 (en) | 2016-06-29 |
TW201244752A (en) | 2012-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5941732B2 (en) | Emulsified composition | |
JP5326028B2 (en) | Emulsified composition | |
WO2011004589A1 (en) | Emulsified composition | |
JP4926420B2 (en) | Emulsified composition | |
US9278059B2 (en) | Emulsified cosmetic composition | |
JP5961071B2 (en) | Emulsified composition | |
JP5342736B2 (en) | Oil-in-water emulsion and method for producing the same | |
JP5690516B2 (en) | Emulsified composition | |
JP6423701B2 (en) | Cosmetics | |
JP2006290751A (en) | Oil-in-water type emulsion and method for producing the same | |
JP5690517B2 (en) | Emulsified composition | |
JP6552280B2 (en) | Scalp cosmetic | |
JP5063064B2 (en) | Ceramide lipid dispersion | |
JP7333303B2 (en) | Skin topical agent | |
JP2010265268A (en) | Composition for skin care, use and method for producing the same | |
JP7478534B2 (en) | Emulsion composition | |
JP2020200283A (en) | Sheet-like cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141217 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150903 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160510 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160523 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5941732 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |